chaga
diseas
caus
trypanosoma
cruzi
devast
parasit
infect
affect
million
peopl
although
mani
effort
made
develop
immunotherapi
avail
vaccin
deadli
infect
one
major
hurdl
ration
approach
develop
cruzi
vaccin
limit
inform
protein
produc
differ
phylogenet
lineag
strain
stage
parasit
adapt
nanohplc
system
perform
onlin
lcmsm
use
autosampl
inject
elut
salt
solut
first
dimens
separ
applic
methodolog
proteom
analysi
infect
trypomastigot
stage
cruzi
led
identif
nonredund
protein
furthermor
identifi
sequenc
compris
surfac
protein
glycosylphosphatidylinositol
gpi
anchor
relat
parasit
pathogenesi
immunoinformat
analysi
reveal
thousand
potenti
peptid
high
affin
major
histocompat
complex
mhc
class
ii
present
high
divers
protein
express
trypomastigot
surfac
may
mani
implic
hostcel
invas
immunoevas
mechan
trigger
parasit
final
perform
ration
approach
filter
potenti
epitop
could
test
valid
develop
chaga
diseas
vaccin
chaga
diseas
american
trypanosomiasi
consid
neglect
infecti
diseas
estim
million
case
latin
america
death
annual
chaga
diseas
becom
public
health
concern
us
europ
due
larg
number
asymptomat
infect
peopl
migrat
endem
area
addit
autochthon
case
alreadi
report
us
etiolog
agent
chaga
diseas
protozoan
parasit
trypanosoma
cruzi
four
lifecycl
stage
form
name
epimastigot
metacycl
trypomastigot
amastigot
bloodstream
trypomastigot
two
distinct
host
ie
triatomin
insect
mammal
natur
cycl
infect
bloodstream
trypomastigot
form
ingest
triatomin
insect
vector
popularli
known
kiss
bug
blood
meal
insect
midgut
trypomastigot
differenti
noninfect
epimastigot
form
reproduc
binari
fission
posterior
region
gut
hindgut
upon
nutrit
stress
epimastigot
transform
infect
metacycl
trypomastigot
form
releas
excreta
blood
meal
parasit
penetr
host
bloodstream
bite
wound
expos
mucosa
infect
varieti
nucleat
cell
insid
cell
metacycl
trypomastigot
immedi
escap
parasitophor
vacuol
transform
prolif
amastigot
form
replic
asexu
binari
divis
sever
divis
cycl
amastigot
differenti
trypomastigot
releas
extracellular
milieu
eventu
reach
bloodstream
infect
new
cell
ingest
kiss
bug
complet
natur
life
cycl
current
therapi
chaga
diseas
base
two
drug
benznidazol
nifurtimox
compound
partial
efficaci
chronic
phase
diseas
sever
side
effect
moreov
thu
far
avail
vaccin
treatment
andor
prevent
human
chaga
diseas
recent
year
sever
studi
focus
host
immun
respons
cruzi
although
promis
progress
made
difficulti
use
ration
approach
develop
vaccin
cruzi
restrict
inform
protein
express
cell
surfac
differ
parasit
stage
strain
phylogenet
lineag
cruzi
cover
thick
layer
glycosylphosphatidylinositol
gpi
anchor
molecul
encod
multigen
famili
mucin
tcmuc
mucinassoci
surfac
protein
masp
transsialidas
ts
glycoprotein
one
hundr
member
howev
lack
posit
correl
level
transcript
protein
make
difficult
use
approach
microarray
cdna
librari
map
express
sequenc
thu
use
proteom
approach
interest
reliabl
altern
analyz
gene
express
cruzi
instanc
largescal
proteom
studi
cruzi
brazil
strain
identifi
nonredund
protein
individu
protein
comb
data
four
stage
parasit
multidimension
liquid
chromatographi
mdlc
coupl
tandem
mass
spectrometri
msm
proteom
analysi
first
introduc
john
yate
group
becam
one
popular
approach
analyz
largescal
proteom
sampl
approach
protein
complex
mixtur
sampl
chemic
enzymat
digest
result
thousand
peptid
analyz
mdlcmsm
first
dimens
separ
gener
done
strongcat
exchang
scx
stronganion
exchang
sax
revers
phase
rp
hydrophil
interact
hilic
even
mix
bed
scx
sax
chromatographi
capillari
column
wherea
second
dimens
rp
chromatographi
wide
use
compat
ms
solvent
adapt
nanohplc
simpl
way
perform
onlin
twodimension
liquid
chromatographi
coupl
tandem
mass
spectrometri
lcmsm
analysi
use
autosampl
inject
elut
peptid
scx
capillari
column
appli
new
method
analysi
proteom
infect
host
cellderiv
trypomastigot
form
highli
virul
strain
cruzi
result
show
substanti
increas
trypomastigot
proteom
coverag
compar
previou
studi
moreov
use
bioinformat
analysi
proteom
data
identifi
protein
put
surfac
protein
predict
numer
potenti
epitop
theoret
highbind
affin
class
ii
major
histocompat
complex
mhc
tissu
culturederiv
trypomastigot
form
cruzi
strain
obtain
day
infect
greenmonkey
kidney
epitheli
cell
llcmk
atcc
manassa
va
maintain
co
atmospher
dmem
supplement
fetal
bovin
serum
describ
trypomastigot
collect
centrifug
min
wash
time
phosphatebuff
salin
solut
pb
ph
resuspend
pbscontain
proteas
inhibitor
cocktail
sigma
aldrich
parasit
lysi
perform
sonic
sampl
sec
amplitud
use
vibracel
sonic
sonic
newtown
ct
lysi
sampl
centrifug
min
solubl
protein
fraction
separ
insolubl
protein
quantifi
bicinchonin
acid
bca
kit
pierc
accord
manufactur
protocol
quantif
one
mg
solubl
protein
equival
number
parasit
pellet
note
possibl
quantifi
protein
fraction
insolubl
precipit
trichloroacet
acid
min
ice
bath
centrifug
min
wash
icecold
aceton
dri
vacuum
centrifug
vacufug
eppendorf
protein
redissolv
nh
hco
contain
urea
disulfid
bound
reduc
mm
dithiothreitol
min
cystein
residu
alkyl
mm
iodoacetamid
min
room
temperatur
protect
light
protein
digest
sequencinggrad
trypsin
promega
h
reaction
stop
addit
formic
acid
fa
peptid
desalt
phase
extract
cartridg
ml
discoveri
supelco
sigma
aldrich
cartridg
activ
ml
methanol
equilibr
ml
trifluoroacet
acid
tfa
load
wash
ml
tfa
sampl
elut
ml
tfa
dri
vacuum
centrifug
eppendorf
equival
sampl
dissolv
fa
load
onto
strongcat
exchang
scx
microcolumn
manufactur
poro
hs
resin
appli
biosystem
micropipett
tip
axygen
bioscienc
previous
equilibr
fa
elut
carri
increas
nacl
concentr
mm
nacl
fa
ph
follow
mm
nacl
mm
ammonium
acet
ph
ensu
fraction
dri
vacuum
centrifug
desalt
use
inhous
reversephas
microcolumn
manufactur
poro
resin
mgml
suspens
isopropanol
appli
biosystem
micropipett
tip
wash
methanol
equilibr
microcolumn
tfa
sampl
load
wash
tfa
peptid
elut
tfa
dri
vacuum
centrifug
eppendorf
onlin
offlin
lcmsm
perform
plu
system
eksig
dublin
ca
connect
ltq
xletd
esim
thermo
fisher
scientif
san
jose
ca
system
compris
one
loop
one
scx
trap
column
optipak
optim
technolog
two
trap
column
optipak
one
capillari
column
proteopep
ii
cm
new
object
figur
onlin
scx
fraction
first
dimens
peptid
load
scx
trap
column
peptid
elut
use
autosampl
inject
increas
salt
concentr
mm
nacl
fa
ph
follow
one
inject
mm
nacl
ammonium
acet
ph
elut
peptid
automat
load
column
wash
solvent
solvent
fa
flow
rate
min
offlinefraction
peptid
load
directli
onto
column
wash
solvent
flow
rate
min
second
dimens
peptid
separ
capillari
column
nlmin
flow
rate
use
linear
gradient
solvent
b
min
solvent
b
fa
follow
min
wash
solvent
b
min
solvent
b
electrospray
set
kv
ion
trap
set
maximum
inject
time
ms
full
scan
ms
msm
scan
abund
ion
select
collisioninduc
dissoci
cid
isol
width
amu
normal
collis
energi
dynam
exclus
set
fragment
ion
twice
exclud
min
msm
spectra
peptid
da
least
ion
minimum
count
convert
dta
file
use
biowork
thermo
fisher
scientif
databas
search
perform
use
turbosequest
algorithm
collect
sequenc
cruzi
bovin
human
keratin
porcin
trypsin
download
march
th
genbank
forward
revers
orient
form
dataset
sequenc
paramet
databas
search
follow
trypsin
cleavag
termini
one
miss
cleavag
allow
da
peptidemass
toler
da
fragmentmass
toler
cystein
carbamidomethyl
methionin
oxid
fix
variabl
modif
respect
dataset
filter
protein
xcorr
singli
doubli
triplycharg
peptid
respect
dataset
convert
xml
file
combin
use
inhous
written
perl
wwwperlorg
script
algorithm
basic
assembl
peptid
protein
sequenc
search
peptid
sequenc
use
blast
algorithm
consid
ident
assembl
perform
intel
core
mhz
comput
gb
ram
memori
instal
debianlinux
wwwdebianorg
postgresql
rdm
wwwpostgresqlorg
redund
protein
hit
assembl
protein
group
sinc
imposs
determin
protein
actual
produc
abund
protein
estim
exponenti
modifi
protein
abund
index
empai
previous
describ
top
hit
protein
group
annot
go
use
goblet
algorithm
http
gobletmolgenmpgdecgibingobletwebappgobletcgi
go
analysi
carri
octob
th
invertebr
taxonomi
evalu
threshold
gpi
predict
analysi
perform
use
fraganchor
http
naveticshawaiiedufraganchornnhmmnnhmmhtml
describ
sequenc
high
probabl
accept
potenti
gpianchor
signal
peptid
predict
done
use
signalp
http
wwwcbsdtudkservicessignalp
use
hidden
markov
model
signal
peptid
gpianchor
sequenc
surfac
protein
remov
use
inhous
written
perl
script
base
posit
obtain
fraganchor
signalp
softwar
epitop
analysi
done
use
averag
predict
bind
mode
immun
epitop
databas
analysi
resourc
iedb
predict
tool
http
toolsimmuneepitopeorg
mhci
predict
perform
b
allel
mous
whole
proteom
dataset
wherea
mhcii
b
allel
mous
surfac
protein
dataset
epitop
high
bind
affin
ic
nm
accept
analysi
onlin
lcmsm
wide
use
proteom
applic
case
hplc
compos
least
two
binari
pump
one
pump
set
first
dimens
gradient
ie
scx
sax
wherea
pump
set
gradient
second
dimens
rplcmsm
separ
done
three
dimens
hplc
quaternari
pump
requir
first
two
dimens
separ
adapt
nanohplc
simpl
way
perform
onlin
lcmsm
separ
without
need
hplc
multipl
pump
design
first
dimens
driven
primari
hplc
pump
set
constant
flow
acn
basic
load
wash
sampl
peptid
mixtur
first
load
scxtrap
column
stepwis
saltgradi
perform
inject
differ
concentr
nacl
solut
column
volum
use
autosampl
elut
peptid
captur
onlin
one
two
rptrap
column
wash
setup
salt
gradient
run
first
rptrap
column
rp
gradient
simultan
run
second
rptrap
column
figur
next
run
rp
gradient
run
first
rptrap
column
scx
elut
second
rptrap
column
thu
elimin
time
gap
run
figur
moreov
approach
number
differ
elut
solvent
limit
number
pump
hplc
thu
could
easili
adapt
run
threedimension
lcmsm
test
possibl
use
differ
elut
solvent
last
step
scx
perform
acn
instead
acn
mm
ammonium
acet
ph
instead
fa
ph
without
notic
chang
column
pressur
data
shown
indic
system
might
easili
adapt
separ
next
estim
repeat
system
ran
sampl
twice
tabl
sampl
c
differ
number
detect
peptid
protein
group
similar
previou
report
group
mdlcmsm
recent
taylor
colleagu
develop
similar
approach
perform
lcm
use
lcm
system
base
autosampl
inject
perform
first
dimens
elut
howev
system
differ
sinc
base
vent
column
separ
setup
column
divid
two
part
separ
splitter
proxim
part
compos
two
trap
column
ie
scx
follow
rp
distal
part
compos
analyt
rp
column
load
scx
separ
wash
flow
direct
wast
splitter
separ
column
ms
thu
scx
rp
separ
perform
simultan
also
test
vent
column
setup
perform
lcm
found
effici
wash
salt
data
shown
might
due
fact
wash
step
part
flow
consequ
salt
went
analyt
column
anoth
advantag
system
describ
time
gap
lcm
run
maxim
use
equip
hand
vent
column
approach
might
provid
better
separ
resolut
sinc
dead
volum
smaller
taken
togeth
conclud
autosamplerbas
gradient
simpl
robust
inexpens
altern
perform
onlin
separ
also
worth
point
approach
requir
minimum
modif
lcmsm
system
order
evalu
perform
autosamplerbas
gradient
compar
methodolog
offlin
separ
use
cruzi
trypomastigot
tryptic
digest
test
sampl
briefli
trypomastigot
lyse
sonic
centrifug
result
pellet
insolubl
protein
supernat
solubl
protein
digest
trypsin
equival
use
onlin
offlin
separ
offlin
separ
carri
scx
microcolumn
wherea
onlin
perform
use
autosamplerbas
gradient
figur
could
notic
onlin
separ
led
identif
protein
group
compar
offlin
separ
tabl
sampl
insolubl
protein
onlin
separ
increas
number
identifi
protein
group
wherea
solubl
protein
sampl
number
increas
tabl
investig
onlin
separ
better
perform
sum
number
peptid
fraction
includ
peptid
elut
one
fraction
obtain
similar
number
analysi
insolubl
protein
peptid
onlin
offlin
separ
respect
lower
number
peptid
detect
offlin
separ
solubl
protein
peptid
peptid
onlin
separ
tabl
howev
number
uniqu
peptid
count
repeat
peptid
elut
multipl
fraction
significantli
differ
distinct
fraction
method
compar
number
uniqu
peptid
sum
peptid
fraction
contain
redund
peptid
elut
one
fraction
estim
efficaci
separ
method
onlin
separ
show
peptid
elut
one
fraction
wherea
offlin
separ
number
tabl
taken
togeth
result
clearli
show
superior
perform
autosamplerbas
onlin
separ
comparison
offlin
separ
interestingli
recent
shown
autosamplerbas
gradient
superior
perform
also
compar
convent
lcm
system
superior
perform
propos
due
effici
deliveri
salt
solut
autosamplergradi
next
studi
protein
produc
trypomastigot
combin
five
lcm
ms
run
assembl
peptid
protein
redund
protein
protein
group
dataset
filter
protein
probabl
sum
crosscorrel
score
distinct
peptid
result
falsediscoveri
rate
protein
level
total
individu
protein
identifi
correspond
protein
group
total
protein
protein
group
cruzi
wherea
protein
protein
group
contamin
medium
sampl
prepar
tabl
tabl
function
categor
identifi
protein
group
perform
gene
ontolog
go
annot
seventyon
percent
sequenc
annot
molecular
function
abund
activ
enzymaticcatalyt
activ
emphasi
hydrolas
transferas
oxidoreductas
wellrepres
categori
transport
bind
activ
figur
tabl
cellular
compon
categori
notic
protein
intracellular
associ
membran
organel
figur
tabl
among
biolog
process
categori
half
protein
involv
metabol
figur
tabl
interestingli
protein
group
annot
involv
interact
organ
categori
particularli
pathogenesi
figur
tabl
protein
superfamili
protein
four
hypothet
protein
one
kda
antigen
member
shown
essenti
parasit
virul
member
famili
transsialidas
activ
abl
therefor
transfer
sialic
acid
host
parasit
glycoconjug
mucin
involv
hostcel
invas
escap
host
immun
member
superfamili
nevertheless
transsialidas
activ
play
key
role
adhes
invas
host
cell
modul
host
immun
respons
although
detect
go
annot
superfamili
surfac
protein
mucin
known
involv
pathogenesi
chaga
diseas
thu
increas
number
protein
group
implic
pathogen
process
figur
tabl
mucin
gpi
anchor
shown
strong
proinflammatori
agent
activ
tolllik
receptor
recent
data
lab
shown
activ
pathway
lead
signific
increas
hostcel
invas
parasit
torrecilha
nakayasu
et
al
unpublish
data
gpianchor
metalloproteinas
also
seem
implic
hostcel
invas
sum
current
studi
identifi
high
number
surfac
glycoprotein
ie
mucin
involv
virul
attract
target
develop
immunotherapi
cruzi
treatment
chaga
diseas
current
limit
two
drug
exhibit
high
toxic
medium
efficaci
chronic
stage
furthermor
effect
human
vaccin
avail
prevent
treatment
chaga
diseas
sinc
cruzi
resid
least
part
life
cycl
insid
host
cell
vaccin
base
cytotox
lymphocyt
ctl
seem
attract
approach
ctl
play
central
role
protect
immun
protozoa
lead
longterm
resist
mani
parasit
insid
cell
peptid
deriv
pathogen
load
onto
mhc
class
molecul
endoplasm
reticulum
transport
cell
surfac
present
cytotox
cell
peptidemhc
complex
recogn
tcell
receptor
tcr
essenti
activ
ctl
recent
variou
tool
develop
predict
optimum
peptid
could
present
mhc
allel
despit
limit
epitop
predict
analysi
immunoinformat
comput
immunolog
thu
could
help
find
narrow
best
candid
vaccin
develop
sever
recent
studi
use
immunoinformat
shown
promis
result
advanc
new
immunotherapi
varieti
pathogen
includ
protozoan
parasit
ie
cruzi
plasmodium
vivax
bacteria
virus
despit
use
thu
far
test
potenti
cruzi
immunogen
base
systemat
proteom
mhc
predict
analysi
thu
next
perform
predict
analysi
mhci
present
identifi
protein
protein
group
identifi
cruzi
trypomastigot
predict
done
present
allel
b
inbr
mous
strain
one
use
test
experiment
vaccin
analysi
result
predict
protein
group
individu
protein
put
epitop
high
bind
affin
nm
figur
sinc
high
number
predict
epitop
found
investig
way
filter
data
fortier
et
al
carri
detail
peptidom
analysi
cancer
cell
show
abundantli
express
gene
one
respect
peptid
frequent
present
mhc
class
thu
decid
filter
data
consid
peptid
predict
highli
abund
protein
use
cutoff
abund
protein
calcul
empai
filter
step
predict
peptid
remain
figur
investig
whether
peptid
ident
mous
human
protein
peptid
ident
human
mous
sequenc
also
remov
analysi
result
predict
epitop
figur
tabl
predict
mhc
class
epitop
cruzi
ts
sequenc
previous
carri
show
immunodomin
epitop
vari
accord
parasit
strain
thu
martin
et
al
propos
cruzi
evad
cytotox
cell
respons
differ
subset
ts
protein
express
cell
surfac
parasit
cell
strain
epitop
predict
one
sequenc
fulli
match
predict
made
brazil
cl
brenner
strain
support
idea
differ
parasit
strain
express
uniqu
subset
surfac
protein
even
gene
differ
strain
might
also
present
signific
variat
thu
new
proteom
dataset
cruzi
strain
also
help
discoveri
protein
subset
commonli
express
sever
strain
parasit
predict
peptid
may
bind
mhcii
molecul
could
drastic
reduc
number
experi
requir
identifi
potenti
cell
epitop
therefor
could
acceler
discoveri
new
vaccin
candid
mhc
ii
present
peptid
deriv
endocytos
protein
helper
lymphocyt
htl
stimul
cellular
humor
immun
pathogen
surfac
protein
gener
primari
target
antibodybas
vaccin
sinc
expos
direct
contact
immun
system
thu
next
focus
analysi
cruzi
surfac
protein
predict
mhc
ii
present
although
centrifug
highperform
separ
techniqu
expect
notic
twoto
threefold
enrich
surfac
protein
insolubl
protein
fraction
tabl
total
protein
group
individu
protein
annot
surfac
protein
identifi
surfac
protein
famili
protein
group
protein
masp
protein
group
protein
mucin
tcmuc
ii
protein
group
protein
protein
group
protein
tolt
protein
group
protein
mucinlik
protein
group
protein
yasp
recent
renam
tctasv
cruzi
trypomastigot
alanin
serin
valinerich
protein
protein
group
protein
tabl
tabl
interestingli
found
high
number
masp
tcmuc
ii
mucin
sequenc
protein
difficult
studi
convent
proteom
analysi
sinc
like
highli
glycosyl
sever
gene
seem
express
time
decreas
stoichiometri
individu
protein
thu
possibl
number
express
masp
tcmuc
ii
mucin
found
studi
still
underestim
determin
number
protein
might
gpianchor
perform
predict
analysi
use
fraganchor
algorithm
found
protein
group
individu
protein
high
probabl
gpianchor
tabl
entri
protein
group
protein
previous
annot
surfac
protein
tabl
recent
perform
genomewis
gpianchor
predict
analysi
found
cruzi
gene
encod
possibl
gpianchor
protein
number
much
higher
compar
eukaryot
predict
gpianchor
protein
expect
proteom
express
sever
gpianchor
surfac
protein
isoform
parasit
may
act
backup
escap
mechan
thu
even
isoform
target
antibodi
other
function
promot
parasit
adhes
invas
host
cell
next
perform
predict
analysi
put
epitop
mhc
class
ii
present
use
annot
membran
predict
gpianchor
protein
first
analysi
led
identif
epitop
high
bind
affin
nm
protein
group
protein
respect
figur
look
care
predict
epitop
found
bia
predict
local
hydrophob
region
signal
peptid
gpianchor
sequenc
howev
domain
process
endoplasm
reticulum
therefor
present
matur
protein
circumv
issu
sequenc
cut
base
predict
signal
peptid
use
signalp
gpianchor
predict
use
fraganchor
perform
mch
class
iibind
predict
truncat
version
sequenc
possibl
epitop
ic
nm
found
protein
group
individu
protein
respect
figur
high
number
predict
epitop
biolog
relev
howev
detriment
choos
potenti
target
vaccin
develop
therefor
filter
data
base
protein
abund
way
done
mhci
predict
filter
low
abund
protein
empai
peptid
predict
present
mhcii
molecul
figur
filter
peptid
similar
human
mous
sequenc
ident
epitop
found
best
candid
vaccin
target
figur
show
cruzi
trypomastigot
concomitantli
express
hundr
gpianchor
glycoprotein
cell
surfac
data
corrobor
significantli
expand
previou
observ
trypomastigot
proteom
furthermor
silico
predict
analysi
indic
thousand
sequenc
potenti
mhc
class
epitop
thu
hypothes
extrem
high
number
protein
express
parasit
cell
surfac
may
lead
dilut
epitop
present
host
cell
thu
lead
ineffect
cytotox
cell
respons
facilit
parasit
perpetu
within
host
recent
studi
also
show
antibodi
one
specif
ts
sequenc
fail
inhibit
enzymat
activ
whole
cell
lysat
support
idea
mani
sequenc
express
time
moreov
antibodi
partial
inhibit
host
cell
invas
probabl
recogn
small
subset
molecul
take
consider
rare
except
patient
acut
chronic
chaga
diseas
divers
geograph
locat
latin
america
high
titer
trypanolyt
antibodi
ii
protect
antibodi
thought
one
major
host
immun
mechan
respons
control
parasitemia
acut
chronic
stage
chaga
diseas
iii
highli
immunogen
epitop
abundantli
express
major
immunodomin
gpianchor
glycoprotein
mammaldwel
cruzi
trypomastigot
form
normal
absent
human
tissu
propos
effici
human
vaccin
cruzi
includ
immunodomin
bcell
epitop
well
cell
epitop
univers
express
differ
parasit
strain
lineag
develop
simpl
robust
approach
perform
onlin
lcmsm
analysi
use
autosampl
inject
elut
peptid
first
dimens
column
applic
methodolog
analyz
whole
cell
lysat
cruzi
trypomastigot
led
identif
nonredund
protein
cruzi
result
show
trypomastigot
stage
cruzi
rich
cell
surfac
virul
factor
mucin
express
sever
isoform
virul
factor
may
play
central
role
process
host
cell
invas
immunomodul
parasit
furthermor
ration
immunoinformat
predict
analysi
put
mhc
epitop
identifi
variou
peptid
could
use
vaccin
target
hope
find
could
help
design
develop
effect
immunotherapeut
prevent
andor
treat
chaga
diseas
refer
web
version
pubm
central
supplementari
materi
autosamplerbas
gradient
twodimension
liquid
chromatographi
tandem
mass
spectrometri
system
first
cycl
tryptic
digest
load
scx
trap
column
unbound
peptid
captur
rptrap
column
second
cycl
autosampl
inject
salt
solut
scx
elut
peptid
captur
rptrap
column
acetonitril
gradient
run
analyt
column
next
cycl
higherconcentr
salt
solut
inject
scxtrap
column
peptid
trap
acetonitril
gradient
run
second
third
cycl
altern
repeat
scx
elut
step
analyz
workflow
cruzi
trypomastigot
wholecel
lysat
analysi
lcmsm
trypomastigot
lyse
sonic
centrifug
min
sampl
quantifi
digest
trypsin
result
peptid
fraction
scx
chromatographi
either
onlin
use
autosampl
perform
elut
offlin
use
inhous
scx
microcolumn
fraction
analyz
rplcmsm
identifi
protein
submit
go
epitop
predict
analys
gene
ontolog
analysi
go
analysi
perform
use
goblet
algorithm
select
repres
categori
molecular
function
cellular
compon
biolog
process
shown
graph
complet
list
see
tabl
predict
major
compat
complexbind
peptid
workflow
predict
filter
mhc
class
mhc
class
ii
b
peptid
shown
perform
comparison
number
peptid
per
fraction
onlin
offlin
fraction
solubl
insolubl
cruzi
protein
onlin
fraction
perform
acn
wherea
offlin
fraction
done
acn
